Immunoprotective Sertoli cells: Making allogeneic and xenogeneic transplantation feasible

Reproduction

Volumn 139, Issue 3, 2010, Pages 495-504

  Mital, Payal ^a   Kaur, Gurvinder ^a   Dufour, Jannette M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; CYTOKINE; FAS LIGAND; GRANZYME;

ALLOTRANSPLANTATION; APOPTOSIS; CELL PROTECTION; CELL STRUCTURE; CELL THERAPY; CYTOLYSIS; CYTOTOXIC LYMPHOCYTE; DIABETES MELLITUS; FEASIBILITY STUDY; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PANCREAS ISLET; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SERTOLI CELL; T LYMPHOCYTE; XENOGRAFT;

ANIMALS; CYTOPROTECTION; FEASIBILITY STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MALE; MODELS, BIOLOGICAL; SERTOLI CELLS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77149150911     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-09-0384     Document Type: Review

References (69)

1. Akimaru K, Stuhlmiller GM & Seigler HF 1981 Allotransplantation of insulinoma into the testis of diabetic rats. Transplantation 32 227-232.
2. Allison J, Georgiou HM, Strasser A & Vaux DL 1997 Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. PNAS 94 3943-3947.
3. Bailey R & Griswold MD 1999 Clusterin in the male reproductive system: localization and possible function. Molecular and Cellular Endocrinology 151 17-23.
4. Barker CF & Billingham RE 1977 Immunologically privileged sites. Advances in Immunology 25 1-54.
5. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A & Duke RC 1995 A role for CD95 ligand in preventing graft rejection. Nature 377 630-632.
6. Bhushan S, Schuppe HC, Tchatalbachev S, Fijak M, Weidner W, Chakraborty T & Meinhardt A 2009 Testicular innate immune defense against bacteria. Molecular and Cellular Endocrinology 306 37-44.
7. Bladergroen BA, Strik MC, Bovenschen N, van Berkum O, Scheffer GL, Meijer CJ, Hack CE & Kummer JA 2001 The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. Journal of Immunology 166 3218-3225.
8. Cameron DF, Whittington K, Schultz RE & Selawry HP 1990 Successful islet/abdominal testis transplantation does not require Leydig cells. Transplantation 50 649-653.
9. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R & Lascurain R 2009 Cell death mechanisms induced by cytotoxic lymphocytes. Cellular & Molecular Immunology 6 15-25.
10. Chen JJ, Sun Y & Nabel GJ 1998 Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282 1714-1717.
11. Choi C & Benveniste EN 2004 Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Research Reviews 44 65-81.
12. Cunningham TD, Jiang X & Shapiro DJ 2007 Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity. Cellular Immunology 245 32-41.
13. De Cesaris P, Filippini A, Cervelli C, Riccioli A, Muci S, Starace G, Stefanini M & Ziparo E 1992 Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes. Biochemical and Biophysical Research Communications 186 1639-1646.
14. Dufour JM, Rajotte RV, Kin T & Korbutt GS 2003a Immunoprotection of rat islet xenografts by cotransplantation with Sertoli cells and a single injection of antilymphocyte serum. Transplantation 75 1594-1596.
15. Dufour JM, Rajotte RV, Korbutt GS & Emerich DF 2003b Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunological Investigations 32 275-297.
16. Dufour JM, Rajotte RV, Seeberger K, Kin T & Korbutt GS 2003c Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats. Xenotransplantation 10 577-586.
17. Dufour JM, Hemendinger R, Halberstadt CR, Gores P, Emerich DF, Korbutt GS & Rajotte RV 2004 Genetically engineered Sertoli cells are able to survive allogeneic transplantation. Gene Therapy 11 694-700.
18. Dufour JM, Hamilton M, Rajotte RV & Korbutt GS 2005 Neonatal porcine Sertoli cells inhibit human natural antibody-mediated lysis. Biology of Reproduction 72 1224-1231.
19. Dufour JM, Dass B, Halley KR, Korbutt GS, Dixon DE & Rajotte RV 2008a Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells. Cell Transplantation 17 525-534.
20. Dufour JM, Lord SJ, Kin T, Rayat GR, Dixon DE, Bleackley RC, Korbutt GS & Rajotte RV 2008b Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice. Cell Transplantation 16 1029-1038.
21. Dym M & Fawcett DW 1970 The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biology of Reproduction 3 308-326.
22. Ferguson J & Scothorne RJ 1977a Extended survival of pancreatic islet allografts in the testis of guinea-pigs. Journal of Anatomy 124 1-8.
23. Ferguson J & Scothorne RJ 1977b Further studies on the transplantation of isolated pancreatic islets. Journal of Anatomy 124 9-20.
24. Ferguson TA, Green DR & Griffith TS 2002 Cell death and immune privilege. International Reviews of Immunology 21 153-172.
25. Gores PF, Hayes DH, Copeland MJ, Korbutt GS, Halberstadt C, Kirkpatrick SA & Rajotte RV 2003 Long-term survival of intratesticular porcine islets in nonimmunosuppressed beagles. Transplantation 75 613-618.
26. Griswold MD 1998 The central role of Sertoli cells in spermatogenesis. Seminars in Cell and Developmental Biology 9 411-416.
27. Guazzone VA, Jacobo P, Theas MS & Lustig L 2009 Cytokines and chemokines in testicular inflammation: a brief review. Microscopy Research and Technique 72 620-628.
28. Head JR & Billingham RE 1985 Immune privilege in the testis. II. Evaluation of potential local factors. Transplantation 40 269-275.
29. Head JR, Neaves WB & Billingham RE 1983a Immune privilege in the testis. I. Basic parameters of allograft survival. Transplantation 36 423-431.
30. Head JR, Neaves WB & Billingham RE 1983b Reconsideration of the lymphatic drainage of the rat testis. Transplantation 35 91-95.
31. Hedger MP & Meinhardt A 2003 Cytokines and the immune-testicular axis. Journal of Reproductive Immunology 58 1-26.
32. Hirst CE, Buzza MS, Sutton VR, Trapani JA, Loveland KL & Bird PI 2001 Perforin-independent expression of granzyme B and proteinase inhibitor 9 in human testis and placenta suggests a role for granzyme B-mediated proteolysis in reproduction. Molecular Human Reproduction 7 1133-1142.
33. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG & Baekkeskov S 1997 Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Medicine 3 738-743.
34. Korbutt GS, Elliott JF & Rajotte RV 1997 Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46 317-322.
35. Korbutt GS, Suarez-Pinzon WL, Power RF, Rajotte RV & Rabinovitch A 2000 Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia 43 474-480.
36. Lau HT, Yu M, Fontana A & Stoeckert CJ Jr 1996 Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273 109-112.
37. Lee HM, Lim HG, Oh BC, Park CS, Lee DS & Lee JR 2007a Systemic immune modulation using chemokine receptor 7 expressing porcine Sertoli cells. Xenotransplantation 14 619-626.
38. Lee HM, Oh BC, Lim DP, Lee DS, Cho J, Lee G & Lee JR 2007b Role of complement regulatory proteins in the survival of murine allo-transplanted Sertoli cells. Journal of Korean Medical Science 22 277-282.
39. Lim HG, Lee HM, OhBC & Lee JR 2009 Cell-mediated immunomodulation of chemokine receptor 7-expressing porcine Sertoli cells in murine heterotopic heart transplantation. Journal of Heart and Lung Transplantation 28 72-78.
40. Luca G, Calafiore R, Basta G, Ricci M, Calvitti M, Neri L, Nastruzzi C, Becchetti E, Capitani S, Brunetti P et al. 2001 Improved function of rat islets upon co-microencapsulation with Sertoli's cells in alginate/ poly-L-ornithine. AAPS Pharm Sci Tech 2 E15.
41. Mead R, Hinchliffe SJ & Morgan BP 1999 Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46). Immunology 98 137-143.
42. Naji A & Barker CF 1976 The influence of histocompatibility and transplant site on parathyroid allograft survival. Journal of Surgical Research 20 261-267.
43. O'Rand MG & Romrell LJ 1977 Appearance of cell surface auto- and isoantigens during spermatogenesis in the rabbit. Developmental Biology 55 347-358.
44. Rahman TM, Diakanov I, Selden C & Hodgson H 2005 Co-transplantation of encapsulated HepG2 and rat Sertoli cells improves outcome in a thioacetamide induced rat model of acute hepatic failure. Transplant International 18 1001-1009.
45. Riccioli A, Starace D, D'Alessio A, Starace G, Padula F, De Cesaris P, Filippini A & Ziparo E 2000 TNF-alpha and IFN-gamma regulate expression and function of the Fas system in the seminiferous epithelium. Journal of Immunology 165 743-749.
46. Russell L 1977 Movement of spermatocytes from the basal to the adluminal compartment of the rat testis. American Journal of Anatomy 148 313-328.
47. Russell LD & Griswold MD 1993 The Sertoli Cell. Clearwater, FL: Cache River Press.
48. Russell LD, Ettlin RA, Sinha Hikim AP & Clegg ED 1990 Histological and Histopathological Evaluation of the Testis. Clearwater, FL: Cache River Press.
49. Sanberg PR, Borlongan CV, Saporta S & Cameron DF 1996 Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nature Biotechnology 14 1692-1695.
50. Selawry HP 1994 Islet transplantation to immunoprivileged sites. In Pancreatic Islet Transplantation: Immunomodulation of Pancreatic Islets, pp 75-86. Eds RP Lanza&WL Chick. Austin, TX: Landes/CRC Press.
51. Selawry HP & Cameron DF 1993 Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplantation 2 123-129.
52. Selawry HP & Whittington K 1984 Extended allograft survival of islets grafted into intra-abdominally placed testis. Diabetes 33 405-406.
53. Selawry HP & Whittington KB 1988 Prolonged intratesticular islet allograft survival is not dependent on local steroidogenesis. Hormone and Metabolic Research 20 562-565.
54. Selawry HP, Kotb M, Herrod HG & Lu ZN 1991 Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site. Transplantation 52 846-850.
55. Shamekh R, El-Badri NS, Saporta S, Pascual C, Sanberg PR & Cameron DF 2006 Sertoli cells induce systemic donor-specific tolerance in xenogenic transplantation model. Cell Transplantation 15 45-53.
56. Sipione S, Simmen KC, Lord SJ, Motyka B, Ewen C, Shostak I, Rayat GR, Dufour JM, Korbutt GS, Rajotte RV et al. 2006 Identification of a novel human granzyme B inhibitor secreted by cultured Sertoli cells. Journal of Immunology 177 5051-5058.
57. Suarez-Pinzon W, Korbutt GS, Power R, Hooton J, Rajotte RV & Rabinovitch A 2000 Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factorbeta1- dependent mechanism. Diabetes 49 1810-1818.
58. Takeda Y, Gotoh M, Dono K, Nishihara M, Grochowiecki T, Kimura F, Yoshida T, Ohta Y, Ota H, Ohzato H et al. 1998 Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts. Diabetologia 41 315-321.
59. Trivedi AA, Igarashi T, Compagnone N, Fan X, Hsu JY, Hall DE, John CM & Noble-Haeusslein LJ 2006 Suitability of allogeneic Sertoli cells for ex vivo gene delivery in the injured spinal cord. Experimental Neurology 198 88-100.
60. Tung PS & Fritz IB 1978 Specific surface antigens on rat pachytene spermatocytes and successive classes of germinal cells. Developmental Biology 64 297-315.
61. Valdes-Gonzalez RA, Dorantes LM, Garibay GN, Bracho-Blanchet E, Mendez AJ, Davila-Perez R, Elliott RB, Teran L & White DJ 2005 Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. European Journal of Endocrinology 153 419-427.
62. Valdes-Gonzalez RA, White DJ, Dorantes LM, Teran L, Garibay-Nieto GN, Bracho-Blanchet E, Davila-Perez R, Evia-Viscarra L, Ormsby CE, Ayala-Sumuano JT et al. 2007 Three-yr follow-up of a type 1 diabetes mellitus patient with an islet xenotransplant. Clinical Transplantation 21 352-357.
63. Wang DZ, Skinner S, Elliot R, Escobar L, Salto-Tellez M, Garkavenko O, Khoo A, Lee KO, Calne R&Isaac JR 2005 Xenotransplantation of neonatal porcine islets and Sertoli cells into nonimmunosuppressed streptozotocin-induced diabetic rats. Transplantation Proceedings 37 470-471.
64. Whitmore WF & Gittes RF 1977 Studies on the prostate and testis as immunologically privileged sites. Cancer Treatment Reports 61 217-222.
65. Whitmore WF III, Karsh L & Gittes RF 1985 The role of germinal epithelium and spermatogenesis in the privileged survival of intratesticular grafts. Journal of Urology 134 782-786.
66. Willing AE, Sudberry JJ, Othberg AI, Saporta S, Poulos SG, Cameron DF, Freeman TB & Sanberg PR 1999 Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum. Brain Research Bulletin 48 441-444.
67. Wyatt CR, Law L, Magnuson JA, Griswold MD & Magnuson NS 1988 Suppression of lymphocyte proliferation by proteins secreted by cultured Sertoli cells. Journal of Reproductive Immunology 14 27-40.
68. Yang H & Wright JR Jr 1999 Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation 67 815-820.
69. Yule TD, Montoya GD, Russell LD, Williams TM & Tung KS 1988 Autoantigenic germ cells exist outside the blood-testis barrier. Journal of Immunology 141 1161-1167.